Retatrutide puts diet coaches at risk

Retatrutide could reduce demand for routine diet-coach check-ins by changing appetite regulation. The experimental drug produced up to 24.2% average weight loss at 48 weeks in a Phase 2 obesity trial, but it is not a replacement for medical care. The open question is whether meal-plan accountability survives if appetite becomes easier to control. Send this to a diet coach who thinks the workflow is safe—and comment whether this threatens coaching or just changes it.